Artal Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-500,000
| Closed | -$3.76M | – | 101 |
|
|
2023
Q2 | $3.76M | Hold |
500,000
| – | – | 0.12% | 68 |
|
|
2023
Q1 | $2.26M | Hold |
500,000
| – | – | 0.13% | 77 |
|
|
2022
Q4 | $5.64M | Hold |
500,000
| – | – | 0.31% | 55 |
|
|
2022
Q3 | $4.79M | Hold |
500,000
| – | – | 0.2% | 58 |
|
|
2022
Q2 | $4.05M | Hold |
500,000
| – | – | 0.22% | 63 |
|
|
2022
Q1 | $8.45M | Hold |
500,000
| – | – | 0.35% | 54 |
|
|
2021
Q4 | $10.7M | Hold |
500,000
| – | – | 0.29% | 63 |
|
|
2021
Q3 | $36.9M | Hold |
500,000
| – | – | 0.83% | 26 |
|
|
2021
Q2 | $27.3M | Sell |
500,000
-25,000
| -5% | -$1.37M | 0.55% | 34 |
|
|
2021
Q1 | $38.7M | Buy |
525,000
+225,000
| +75% | +$16.6M | 0.68% | 23 |
|
|
2020
Q4 | $25.9M | Buy |
300,000
+200,000
| +200% | +$17.2M | 0.56% | 45 |
|
|
2020
Q3 | $3.77M | Buy |
+100,000
| New | +$3.77M | 0.09% | 93 |
|